-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.
-
Summary
-
Reata Pharmaceuticals Inc quarterly/annual General and Administrative Expense history and growth rate from Q2 2015 to Q4 2022.
- Reata Pharmaceuticals Inc General and Administrative Expense for the quarter ending December 31, 2022 was $32M, a 4.77% increase year-over-year.
- Reata Pharmaceuticals Inc General and Administrative Expense for the twelve months ending December 31, 2022 was $109M, a 10.4% increase year-over-year.
- Reata Pharmaceuticals Inc annual General and Administrative Expense for 2022 was $109M, a 10.4% increase from 2021.
- Reata Pharmaceuticals Inc annual General and Administrative Expense for 2021 was $99M, a 31.8% increase from 2020.
- Reata Pharmaceuticals Inc annual General and Administrative Expense for 2020 was $75.1M, a 28.9% increase from 2019.
General and Administrative Expense, Trailing 12 Months (USD)
General and Administrative Expense, Quarterly (USD)
General and Administrative Expense, YoY Quarterly Growth (%)